EGFR and non-small cell lung carcinoma: Further, high PD-L1 expression is not only found to accelerate skin carcinogenesis (25) but also associated with tumor differentiation, vascular invasion, and resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment in non-small cell lung cancer (NSCLC) (26, 27).